Trial Details

COMPLETED
Basic Information
Clinical ID c1274
Identifier NCT00713310
Trial Title Assessing the Safety/Efficacy of Asacol Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions DRUG: Asacol 400 mg|DRUG: Asacol 400 mg
Participant Information
Sponsor Warner Chilcott
City Birmingham
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2025-12-08
Primary Completion Date 2025-03-11
Completion Date 2025-03-11